A new trading day began on Friday, with Twist Bioscience Corp (NASDAQ: TWST) stock price down -6.12% from the previous day of trading, before settling in for the closing price of $32.68. TWST’s price has ranged from $11.46 to $43.21 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 60.13%. Meanwhile, its annual earnings per share averaged 14.54%. With a float of $55.30 million, this company’s outstanding shares have now reached $57.56 million.
Considering the fact that the conglomerate employs 919 people, you should pay attention to its efficiency factor.
Twist Bioscience Corp (TWST) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 4.36%, while institutional ownership is 108.70%. The most recent insider transaction that took place on Apr 09 ’24, was worth 18,434. In this transaction Chief Financial Officer of this company sold 556 shares at a rate of $33.16, taking the stock ownership to the 74,444 shares. Before that another transaction happened on Apr 02 ’24, when Company’s Chief Executive Officer sold 1,132 for $32.74, making the entire transaction worth $37,057. This insider now owns 514,149 shares in total.
Twist Bioscience Corp (TWST) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 23.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.54% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Here are Twist Bioscience Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.60, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach -2.67 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Compared to the last year’s volume of 0.92 million, its volume of 0.7 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 27.64%. Additionally, its Average True Range was 1.86.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 44.61%, which indicates a significant increase from 7.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.19% in the past 14 days, which was lower than the 72.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.18, while its 200-day Moving Average is $27.15. Nevertheless, the first resistance level for the watch stands at $31.93 in the near term. At $33.18, the stock is likely to face the second major resistance level. The third major resistance level sits at $34.00. If the price goes on to break the first support level at $29.86, it is likely to go to the next support level at $29.05. Should the price break the second support level, the third support level stands at $27.80.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
With a market capitalization of 1.77 billion, the company has a total of 57,818K Shares Outstanding. Currently, annual sales are 245,110 K while annual income is -204,620 K. The company’s previous quarter sales were 71,500 K while its latest quarter income was -43,010 K.
